Johnson & Johnson vs NovoCure Limited — Stock Comparison

JNJ
Johnson & Johnson
$227.19
▼ 1.16%
vs
NVCR
NovoCure Limited
$16.62
▲ 9.27%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 5.4/10

Q·Score Breakdown

7.1
Bullish
Overall
5.4
Bearish
9.3
Quality
1
6.5
Health
7.4
5.1
Growth
6.7
7.3
Valuation
6.5
6.5
Sentiment
6.8
JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

NVCR

Healthy balance sheet and financial position.

currently unprofitable (-26% margin).

Analyst Consensus

BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $25.21 (+51.7%)
7 analysts

Fundamentals

JNJ
NVCR
26.3×
Trailing P/E
17.9×
Forward P/E
-14.3×
21.8%
Profit Margin
-25.7%
68.0%
Gross Margin
75.4%
26.4%
ROE
-50.0%
9.9%
Revenue Growth
12.3%
-52.9%
Earnings Growth
0.33
Beta
0.82
Price / Book
$546.9B
Market Cap
$1.9B
$146 – $252
52-Week Range
$10 – $20

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →